Home | News | Directories | Calendar | Maps | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

David B. Roth, MD, PhD

David B. Roth, MD, PhD

faculty photo
Simon Flexner Professor of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine

Contact information
6.036 Gates Building
3400 Spruce Street
Philadelphia, PA 19104-4283
Office: 215-615-6510
Fax: 215-662-4063
Education:
BA (Biochemistry)
Rice University, Houston TX, 1981.
MD (with High Honors)
Baylor College of Medicine, Houston TX, 1986.
PhD (Biochemistry)
Baylor College of Medicine, Houston TX, 1988.
Permanent link
 
Perelman School of Medicine > Faculty > Search

Description of Other Expertise

Director, Penn Center for Precision Medicine
Panelist, Panel Discussion at Penn Medicine Advances: "Pathways Leading to Cures", Merion, PA, November, 2013

Selected Publications

Hiemenz MC, Kadauke S, Lieberman DB, Roth DB, Zhao J, Watt CD, Daber RD, Morrissette JJ: Building a Robust Tumor Profiling Program: Synergy between Next-Generation Sequencing and Targeted Single-Gene Testing. PLoS One 11(4): e0152851, Apr 2016 Notes: doi: 10.1371/journal.pone.0152851. eCollection 2016.

Roth D: Young but Powerful: Penn Medicine’s Center for Personalized Diagnostics is on a mission to improve patient care using the power of genomics. The Pathologist(0316), 402, March 2016 Notes: https://thepathologist.com/issues/0316/young-but-powerful/

Lescale C, Abramowski V, Bedora-Faure M, Murigneux V, Vera G, Roth DB, Revy P, de Villartay JP, Deriano L: RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair. Nat Commun 7(10529), Feb 2016.

Wei S, Lieberman D, Morrissette JJ, Baloch ZW, Roth DB, McGrath C: Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience. Cancer Cytopathol Dec 2015.

Martina Mijušković, Yi-Fan Chou Vered Gigi, Cory R. Lindsay, Olga Shestova, Susanna M. Lewis, David B. Roth: Off target V(D)J recombination drives lymphomagenesis and is escalated by loss of the Rag2 C-terminus. Cell Reports 12: 1842-1852, Sept 2015 Notes: 10.1016/j.celrep.2015.08.034

Corrigan-Curay Jacqueline, O'Reilly Marina, Kohn Donald B, Cannon Paula M, Bao Gang, Bushman Frederic D, Carroll Dana, Cathomen Toni, Joung J Keith, Roth David, Sadelain Michel, Scharenberg Andrew M, von Kalle Christof, Zhang Feng, Jambou Robert, Rosenthal Eugene, Hassani Morad, Singh Aparna, Porteus Matthew H: Genome Editing Technologies: Defining a Path to Clinic. Molecular therapy: the journal of the American Society of Gene Therapy 23(5): 796-806, May 2015.

Wilson Melissa A, Morrissette Jennifer J D, McGettigan Suzanne, Roth David, Elder David, Schuchter Lynn M, Daber Robert D: What you are missing could matter: a rare, complex BRAF mutation affecting codons 599, 600, and 601 uncovered by next generation sequencing. Cancer genetics Jun 2014.

Vered Gigi, Susanna Lewis, Olga Shestova, Martina Mijušković, Ludovic Deriano, Wenzhao Meng, Eline T. Luning Prak and David B. Roth: RAG2 mutants alter DSB repair pathway choice in vivo and illuminate the nature of ‘alternative NHEJ’ Nucl. Acids Res. Apr 2014 Notes: In press, doi: 10.1093/nar/gku295.

Gigi V, Lewis S, Shestova O, Mijušković M, Deriano L, Meng W, Luning Prak ET, Roth DB: The "dispensable" C-terminus of RAG2 suppresses alternative NHEJ during repair of physiologic double-strand breaks in developing lymphocytes. Nucleic Acids Research 42(10): 6352-64, April 2014 Notes: doi: 10.1093/nar/gku25.

Lindsay CR, Roth DB: An unbiased method for detection of genome-wide off target effects in cell lines treated with zinc finger nucleases. Methods Mol Biol. 1114 F. Storici (eds.). Page: 353-69, 2014 Notes: doi: 10.1007/978-1-62703-761-7_2.

back to top
Last updated: 04/06/2016
The Trustees of the University of Pennsylvania